CADIAN CAPITAL MANAGEMENT, LP - MIRUM PHARMACEUTICALS INC ownership

MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 99 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.

Quarter-by-quarter ownership
CADIAN CAPITAL MANAGEMENT, LP ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$45,343,535
+38.6%
1,434,922
+13.4%
1.82%
+18.0%
Q2 2023$32,723,532
+85.4%
1,264,922
+72.1%
1.55%
+40.8%
Q1 2023$17,652,826
+139.9%
734,922
+94.7%
1.10%
+105.8%
Q4 2022$7,358,793
-74.3%
377,374
-72.3%
0.53%
-68.1%
Q3 2022$28,674,000
+6.3%
1,364,786
-1.5%
1.68%
-8.0%
Q2 2022$26,972,000
+64.4%
1,385,997
+86.0%
1.82%
+122.5%
Q1 2022$16,405,000745,0000.82%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 3,566,912$62,278,0004.80%
RiverVest Venture Management LLC 1,921,118$33,543,0003.68%
Burrage Capital Management LLC 161,628$2,822,0002.15%
AIGH Capital Management LLC 274,583$4,794,0001.95%
NEA Management Company, LLC 4,187,801$73,119,0001.93%
Novo Holdings A/S 2,445,147$42,692,0001.83%
Sio Capital Management, LLC 494,743$8,638,0001.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,448,912$60,218,0001.19%
Rock Springs Capital Management LP 1,496,525$26,129,0000.55%
Prosight Management, LP 60,250$1,052,0000.49%
View complete list of MIRUM PHARMACEUTICALS INC shareholders